Cargando…

Pre‐existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patients

Coronavirus disease 2019 (COVID‐19) and the Gaucher disease (GD) exhibit lot of resemblances in induction of innate and adaptive immune inflammation that include the immune cells activation and the massive generation of pro‐inflammatory cytokines, chemokines, and growth factors, which are all critic...

Descripción completa

Detalles Bibliográficos
Autor principal:	Pandey, Manoj Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349375/ https://www.ncbi.nlm.nih.gov/pubmed/35942236 http://dx.doi.org/10.1002/ctd2.96

Ejemplares similares

The Comeback of Scarlet Fever
por: Wong, Samson S.Y., et al.
Publicado: (2018)

Estimating Copy-Number Proportions: The Comeback of Sanger Sequencing
por: Seroussi, Eyal
Publicado: (2021)

Glucocorticoid Receptors Are Making a Comeback in Corticotroph Tumorigenesis
por: Theodoropoulou, Marily
Publicado: (2021)

Comeback des Teilchenbeschleunigers
Publicado: (2009)

Coal Poised for a Comeback?
por: Fields, Scott
Publicado: (2004)

Syphilis in China: the great comeback
por: Hesketh, T, et al.
Publicado: (2008)

Brucellosis: Evolution and expected comeback
por: El-Sayed, Amr, et al.
Publicado: (2018)

Comeback of ketamine: resurfacing facts and dispelling myths
por: Kumar, Abhijit, et al.
Publicado: (2021)

The Comeback of the Old Theological Narratives During the Coronavirus Crisis: A Critical Reflection
por: Loffeld, Jan
Publicado: (2021)

Relaunch: how to stage an organizational comeback
por: Rutland, Mark
Publicado: (2013)

Plasmonic Color Makes a Comeback
por: Brazil, Rachel
Publicado: (2020)

The digital stethoscope: Comeback of the phonocardiogram visually
por: Ingawale, Sushrut, et al.
Publicado: (2020)

Lemierre's Syndrome: A Comeback Story
por: Taj, Sobaan, et al.
Publicado: (2022)

Approach to Total Hip Arthroplasty in Gauchers Disease with Pre-Existing Spinopelvic Fusion
por: Vinay, D J, et al.
Publicado: (2022)

Animal models for Gaucher disease research
por: Farfel-Becker, Tamar, et al.
Publicado: (2011)

Consideration of Severe Coronavirus Disease 2019 As Viral Sepsis and Potential Use of Immune Checkpoint Inhibitors
por: Odabasi, Zekaver, et al.
Publicado: (2020)

The influence of pre-existing hypertension on coronavirus disease 2019 patients
por: Wei, Zhi-Yao, et al.
Publicado: (2021)

Progranulin as a Novel Factor in Gaucher Disease
por: Choy, Francis Y.M., et al.
Publicado: (2016)

Tackling COVID19 by Exploiting Pre-existing Cross-Reacting Spike-Specific Immunity
por: Zeng, Qiang, et al.
Publicado: (2020)

Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
por: Roy, Sreeja, et al.
Publicado: (2020)

The Role of Neuroactive Steroids in Analgesia and Anesthesia: An Interesting Comeback?
por: Jevtovic-Todorovic, Vesna, et al.
Publicado: (2023)

Coronavirus Disease 2019 Infection in Children with Pre-Existing Heart Disease
por: Simpson, Megan, et al.
Publicado: (2020)

Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response
por: Lin, Chun-Yang, et al.
Publicado: (2022)

Coronavirus Disease 2019 Severity in Obese Patients May Be Linked to Viral Load and Immune Response
por: Lewis, Alexander M, et al.
Publicado: (2021)

Climate change and the aquatic continuum: A cyanobacterial comeback story
por: Zepernick, Brittany N., et al.
Publicado: (2022)

Low-dose radiation therapy for coronavirus disease-2019 pneumonia: Is it time to look beyond apprehensions?
por: Pandey, Badri Narain
Publicado: (2020)

Pre- and Posttreatment Chest CT Findings: 2019 Novel Coronavirus (2019-nCoV) Pneumonia
por: Duan, Ya-ni, et al.
Publicado: (2020)

Reopening Schools Safely: The Case for Collaboration, Constructive Disruption of Pre-Coronavirus 2019 Expectations, and Creative Solutions
por: Cooper, Dan M., et al.
Publicado: (2020)

IgM responses following SARS-CoV-2 vaccination: insights into protective and pre-existing immunity
por: Fraussen, Judith
Publicado: (2022)

The road to biosimilars in rare diseases ‐ ongoing lessons from Gaucher disease
por: Drelichman, Guillermo, et al.
Publicado: (2019)

Gaucher disease in the COVID-19 pandemic environment: The good, the bad and the unknown
por: Ginns, Edward I., et al.
Publicado: (2021)

Pre-existing immunity against Ad vectors: Humoral, cellular, and innate response, what's important?
por: Fausther-Bovendo, Hugues, et al.
Publicado: (2014)

Evidence and implications of pre‐existing humoral cross‐reactive immunity to SARS‐CoV‐2
por: Mveang Nzoghe, Amandine, et al.
Publicado: (2020)

Ancient Disease Making a Comeback Due to Covid-19 Pandemic
por: Gupta, Sanjeev, et al.
Publicado: (2022)

Outcomes of coronavirus disease‐2019 among veterans with pre‐existing diagnosis of heart failure
por: Rumery, Kyle, et al.
Publicado: (2021)

Proposal for Coronavirus Disease 2019 Management
por: Downs, John B., et al.
Publicado: (2020)

Pre-existing immunity to covid-19 hints at universal coronavirus vaccine
por: Le Page, Michael
Publicado: (2021)

Early prediction of the risk of severe coronavirus disease 2019: A key step in therapeutic decision making
por: Côté, Andréanne, et al.
Publicado: (2020)

Coronavirus Disease 2019 Convalescent Plasma and the Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Titer
por: Bloch, Evan M, et al.
Publicado: (2021)

Evaluating Complement-Mediated Humoral Immunity to P. falciparum Blood Stages
por: Boyle, MJ, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dt2m5hn58ute9mk7rf7fcjenjp